Bone marrow-derived mesenchymal stem cells are capable of mediating hepatitis B virus infection in injured tissues

J Viral Hepat. 2008 Aug;15(8):607-14. doi: 10.1111/j.1365-2893.2008.00978.x. Epub 2008 May 27.

Abstract

We have previously showed that endothelial progenitor cells (EPCs) through uptake of hepatitis B virus (HBV) may play a critical role in mediating extrahepatic HBV diseases. However, it remains to be elucidated whether mesenchymal stem cells (MSCs) are capable of mediating HBV trans-infection into extrahepatic tissues.

Methods and results: In this study, we showed that HBV antigens, HBV DNA and the viral particles were detected in MSCs after 3 days virus challenge. Neither HBV covalently closed circular DNA nor pregenomic RNA were detected in MSCs. Intravenously transplantation of HBV-exposed MSCs into myocardial infarction mouse model resulted in incorporation of HBV into injured heart and other damaged tissues.

Conclusion: These results indicate that MSCs could serve as an additional extrahepatic virus reservoir, which may play a role at least in part in mediating HBV trans-infection into the injured tissues through the process of MSCs recruitment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Viral / analysis
  • Bone Marrow / virology*
  • DNA, Viral / analysis
  • Disease Models, Animal
  • Heart / virology
  • Hepatitis B / transmission*
  • Hepatitis B virus / isolation & purification*
  • Mesenchymal Stem Cells / virology*
  • Mice
  • Myocardial Infarction / therapy

Substances

  • Antigens, Viral
  • DNA, Viral